- 에보트 연구소(ABT)의 3분기 비교 가능한 매출 성장률이 4% 미만인가요?16¢
- Abbott Laboratories (ABT) 3분기 대비 기준 매출 성장률 4%에서 6%?22¢
- Abbott Laboratories(ABT)의 3분기 비교 가능한 매출 성장률이 6%에서 8%인가요?46¢
- 애보트 연구소(ABT) 3분기 비교 가능한 매출 성장률 8%에서 10%?<1¢
- Abbott Laboratories(ABT)의 3분기 비교 가능한 매출 성장률이 10% 이상인가요?11¢
This market will resolve according to Abbott Laboratories' comparable sales growth (year-over-year) for the upcoming third fiscal quarter, as reported in its official company earnings materials. The specified metric will be considered as reported in the company's official earnings materials. Subsequent revisions will not be considered. If the specified company's official earnings materials for the specified quarter are released, and the specified metric is not included, this market will resolve to the lowest bracket. If the specified company does not release quarterly earnings materials for the specified quarter by November 30, 2026, 11:59 PM ET, this market will resolve to the lowest bracket. If the reported value falls exactly between two brackets, this market will resolve to the higher range bracket. If the specified metric is reported as a range rather than a specific number, the midpoint of the range will be used for resolution of this market. The resolution source for this market is Abbott Laboratories' official company earnings materials, including press releases, investor presentations, and regulatory filings. If the specified metric is not reported in these materials, recordings or transcripts of the company's earnings webcast may also be used. Note: This market will resolve based on the most numerically precise version of the specified metric reported in the company's official earnings materials. Only the specified metric will be considered; alternate versions that differ in definition or scope from the specified metric will not be considered.